GuideAI Health

The system provides segment-level arterial characterization from mid-abdomen to ankle using existing imaging for preventive cardiology and executive health programs.

VascularAssist Occlusion Triage is FDA 510(k) cleared for triage and notification, integrating imaging findings into coordinated care.

Interventional radiologist James F. Benenati, MD, FSIR, CMO of Penumbra, joins the GuideAI Health Advisory Board after FDA 510(k) clearance of VAOT.

GuideAI Health Corp. partnered with Boone Heart Institute to evaluate AI-assisted lower limb imaging in a clinical study.

GuideAI Health Corp. (Cboe CA: GDAI) has engaged DS Market Solutions Inc. as market maker for its common shares on Cboe Canada, supporting liquidity.

Independent press and exchange coverage of GuideAI Health Corp. (Cboe Canada: GDAI): the FDA 510(k) clearance of VascularAssist Occlusion Triage.

The interventional radiologists and engineers behind GuideAI Health, the clinical advisors guiding the work, and the milestones the company is measured against.

GuideAI Health offers demos, clinical partnerships, and investor relations, providing data evaluations based on requests.

GuideAI Health builds FDA 510(k) cleared AI imaging intelligence for peripheral arterial disease — reading the arterial tree in scans already taken.

GuideAI Health partners with the Boone Heart Institute to conduct a clinical study and pilot its software. The collaboration aims to integrate GuideAI’s AI-driven cardiac care solutions into clinical workflows at the institute. This marks a key step in validating the technology’s real-world application in patient care.

Oct 2026GlobeNewswireNews article

GuideAI Health Corp. (CN:GDAI) sees a **4.17% stock increase** following FDA clearance of its **vascular AI diagnostic platform**, fueling investor optimism. The platform integrates artificial intelligence into cardiovascular imaging to assist clinicians in identifying vascular conditions. The regulatory approval marks a key milestone for the company’s AI-driven healthcare solutions.

Sep 2026KalkineNews article

GuideAI Health Corp. lists on Cboe Canada, bringing its AI-powered cardiovascular diagnostic tools to public markets. The company specializes in early detection technology for heart-related conditions. This move facilitates broader access to its innovations for investors and healthcare stakeholders.

Jun 2026Yahoo FinanceNews article

GuideAI Health Corp. starts trading on Cboe Canada under the ticker **GDAI**. The company specializes in AI-driven healthcare solutions, including diagnostic tools and patient management platforms. This listing follows its recent expansion into North American markets and aims to enhance investor accessibility.

Jun 2026GlobeNewswireNews article